These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17975102)

  • 1. Shift analysis versus dichotomization of the modified Rankin scale outcome scores in the NINDS and ECASS-II trials.
    Savitz SI; Lew R; Bluhmki E; Hacke W; Fisher M
    Stroke; 2007 Dec; 38(12):3205-12. PubMed ID: 17975102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dichotomized efficacy end points and global end-point analysis applied to the ECASS intention-to-treat data set: post hoc analysis of ECASS I.
    Hacke W; Bluhmki E; Steiner T; Tatlisumak T; Mahagne MH; Sacchetti ML; Meier D
    Stroke; 1998 Oct; 29(10):2073-5. PubMed ID: 9756584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of functional outcome in a national quality register for acute stroke: can simple self-reported items be transformed into the modified Rankin Scale?
    Eriksson M; Appelros P; Norrving B; Terént A; Stegmayr B
    Stroke; 2007 Apr; 38(4):1384-6. PubMed ID: 17322093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis.
    Strbian D; Sairanen T; Meretoja A; Pitkäniemi J; Putaala J; Salonen O; Silvennoinen H; Kaste M; Tatlisumak T;
    Neurology; 2011 Jul; 77(4):341-8. PubMed ID: 21715707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1).
    Lampl Y; Zivin JA; Fisher M; Lew R; Welin L; Dahlof B; Borenstein P; Andersson B; Perez J; Caparo C; Ilic S; Oron U
    Stroke; 2007 Jun; 38(6):1843-9. PubMed ID: 17463313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of age on outcome from thrombolysis in acute stroke: a controlled comparison in patients from the Virtual International Stroke Trials Archive (VISTA).
    Mishra NK; Diener HC; Lyden PD; Bluhmki E; Lees KR;
    Stroke; 2010 Dec; 41(12):2840-8. PubMed ID: 21030710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratification. ECASS Study Group. European Cooperative Acute Stroke Study.
    Steiner T; Bluhmki E; Kaste M; Toni D; Trouillas P; von Kummer R; Hacke W
    Cerebrovasc Dis; 1998; 8(4):198-203. PubMed ID: 9684058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Confirmation of tPA treatment effect by baseline severity-adjusted end point reanalysis of the NINDS-tPA stroke trials.
    Saver JL; Yafeh B
    Stroke; 2007 Feb; 38(2):414-6. PubMed ID: 17234987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the National Institute of Neurological Disorders and Stroke tissue plasminogen activator studies following European Cooperative Acute Stroke Study III patient selection criteria.
    Hemmen TM; Rapp KS; Emond JA; Raman R; Lyden PD
    J Stroke Cerebrovasc Dis; 2010; 19(4):290-3. PubMed ID: 20471855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials.
    Diener HC; Lees KR; Lyden P; Grotta J; Davalos A; Davis SM; Shuaib A; Ashwood T; Wasiewski W; Alderfer V; Hårdemark HG; Rodichok L;
    Stroke; 2008 Jun; 39(6):1751-8. PubMed ID: 18369171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additional outcomes and subgroup analyses of NXY-059 for acute ischemic stroke in the SAINT I trial.
    Lees KR; Davalos A; Davis SM; Diener HC; Grotta J; Lyden P; Shuaib A; Ashwood T; Hardemark HG; Wasiewski W; Emeribe U; Zivin JA;
    Stroke; 2006 Dec; 37(12):2970-8. PubMed ID: 17068304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials.
    Thomalla G; Schwark C; Sobesky J; Bluhmki E; Fiebach JB; Fiehler J; Zaro Weber O; Kucinski T; Juettler E; Ringleb PA; Zeumer H; Weiller C; Hacke W; Schellinger PD; Röther J;
    Stroke; 2006 Mar; 37(3):852-8. PubMed ID: 16439696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated-measures analysis of the National Institute of Neurological Disorders and Stroke rt-PA stroke trial.
    Feng W; Vasquez G; Suri MF; Lakshminarayan K; Qureshi AI
    J Stroke Cerebrovasc Dis; 2011; 20(3):241-6. PubMed ID: 20621509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial.
    Bluhmki E; Chamorro A; Dávalos A; Machnig T; Sauce C; Wahlgren N; Wardlaw J; Hacke W
    Lancet Neurol; 2009 Dec; 8(12):1095-102. PubMed ID: 19850525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.
    National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group
    Ann Emerg Med; 2005 Sep; 46(3):243-52. PubMed ID: 16126134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seven-day NIHSS is a sensitive outcome measure for exploratory clinical trials in acute stroke: evidence from the Virtual International Stroke Trials Archive.
    Kerr DM; Fulton RL; Lees KR;
    Stroke; 2012 May; 43(5):1401-3. PubMed ID: 22308254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
    Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IV thrombolysis and statins.
    Engelter ST; Soinne L; Ringleb P; Sarikaya H; Bordet R; Berrouschot J; Odier C; Arnold M; Ford GA; Pezzini A; Zini A; Rantanen K; Rocco A; Bonati LH; Kellert L; Strbian D; Stoll A; Meier N; Michel P; Baumgartner RW; Leys D; Tatlisumak T; Lyrer PA
    Neurology; 2011 Aug; 77(9):888-95. PubMed ID: 21849650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility-Weighted Modified Rankin Scale as Primary Outcome in Stroke Trials: A Simulation Study.
    Dijkland SA; Voormolen DC; Venema E; Roozenbeek B; Polinder S; Haagsma JA; Nieboer D; Chalos V; Yoo AJ; Schreuders J; van der Lugt A; Majoie CBLM; Roos YBWEM; van Zwam WH; van Oostenbrugge RJ; Steyerberg EW; Dippel DWJ; Lingsma HF;
    Stroke; 2018 Apr; 49(4):965-971. PubMed ID: 29535271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.